In parallel, the tumor suppressor BRD7 radiosensitizes NPC by disrupting USP5-METTL3 binding, which reduces METTL3 stability and inhibits BRCA1/RAD51-mediated DNA damage repair. The gene discussed is METTL3; the disease is neoplasm.